{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:09:27Z","timestamp":1770970167180,"version":"3.50.1"},"reference-count":35,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T00:00:00Z","timestamp":1491782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T00:00:00Z","timestamp":1491782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1002\/jcph.900","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T13:22:48Z","timestamp":1491830568000},"page":"811-817","source":"Crossref","is-referenced-by-count":8,"title":["Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures"],"prefix":"10.1002","volume":"57","author":[{"given":"John A.","family":"Kappes","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice; South Dakota State University; College of Pharmacy; Rapid City Regional Hospital; Rapid City SD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Hayes","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice; South Dakota State University; College of Pharmacy; VA Black Hills Health Care System; Fort Meade SD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe D.","family":"Strain","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice; South Dakota State University; College of Pharmacy; Rapid City Regional Hospital; Rapid City SD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra K.","family":"Farver","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice; South Dakota State University, College of Pharmacy; SD Human Services Center; Yankton SD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,10]]},"reference":[{"key":"10.1002\/jcph.900-BIB0001|jcph900-cit-0001","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.yebeh.2012.06.016","article-title":"Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report","volume":"25","author":"England","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1002\/jcph.900-BIB0002|jcph900-cit-0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1002\/jcph.900-BIB0003|jcph900-cit-0003","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"5 suppl","key":"10.1002\/jcph.900-BIB0004|jcph900-cit-0004","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1111\/j.1528-1157.1993.tb05920.x","article-title":"Advances in the assessment of refractory epilepsy","volume":"34","author":"Schachter","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0005|jcph900-cit-0005","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000123695.22623.32","article-title":"Efficacy and tolerability of the new antiepileptic drugs: II. Treatment of refractory epilepsy","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/jcph.900-BIB0006|jcph900-cit-0006","unstructured":"BRIVIACT [package insert] Atlanta, GA UCB Inc 2016"},{"key":"10.1002\/jcph.900-BIB0007|jcph900-cit-0007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2011.04.064","article-title":"Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties","volume":"664","author":"Gillard","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jcph.900-BIB0008|jcph900-cit-0008","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/bjp.2008.198","article-title":"Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A","volume":"154","author":"Matangne","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jcph.900-BIB0009|jcph900-cit-0009","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","article-title":"Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)","volume":"96","author":"Crowder","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jcph.900-BIB0010|jcph900-cit-0010","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetriacetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jcph.900-BIB0011|jcph900-cit-0011","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.eplepsyres.2009.09.024","article-title":"Brivaracetam (ucb 34714) inhibits Na(+) current in rat cortical neurons in culture","volume":"88","author":"Zona","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcph.900-BIB0012|jcph900-cit-0012","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1365-2125.2006.02829.x","article-title":"The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males","volume":"63","author":"Sargentini-Maier","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/jcph.900-BIB0013|jcph900-cit-0013","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/dmd.107.017129","article-title":"Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects","volume":"36","author":"Sargentini-Maier","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jcph.900-BIB0014|jcph900-cit-0014","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jcph.82","article-title":"Brivaracetam disposition in mild to severe hepatic impairment","volume":"53","author":"Stockis","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1002\/jcph.900-BIB0015|jcph900-cit-0015","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1177\/0091270011431457","article-title":"Brivaracetam disposition in renal impairment","volume":"52","author":"Sargentini-Maier","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1002\/jcph.900-BIB0016|jcph900-cit-0016","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1212\/WNL.0b013e3181ec7f7f","article-title":"Adjunctive brivaracetam for refractory partial-onset seizures","volume":"75","author":"French","year":"2010","journal-title":"Neurology"},{"key":"10.1002\/jcph.900-BIB0017|jcph900-cit-0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1528-1167.2012.03598.x","article-title":"Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial","volume":"54","author":"Paesschen","year":"2013","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0018|jcph900-cit-0018","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/epi.12432","article-title":"Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial","volume":"55","author":"Ryvlin","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0019|jcph900-cit-0019","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/epi.12433","article-title":"Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial","volume":"55","author":"Biton","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0020|jcph900-cit-0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/epi.12391","article-title":"Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial","volume":"55","author":"Kwan","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0021|jcph900-cit-0021","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/epi.13212","article-title":"A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset Sseizures","volume":"56","author":"Klein","year":"2015","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0022|jcph900-cit-0022","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/epi.13409","article-title":"Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy","volume":"57","author":"Klein","year":"2016","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0023|jcph900-cit-0023","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0000000000002545","article-title":"Brivaracetam add-on for refractory focal epilepsy","volume":"86","author":"Lattanzi","year":"2016","journal-title":"Neurology"},{"key":"10.1002\/jcph.900-BIB0024|jcph900-cit-0024","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1212\/WNL.0000000000002864","article-title":"Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies","volume":"87","author":"Ben-Menachem","year":"2016","journal-title":"Neurology"},{"key":"10.1002\/jcph.900-BIB0025|jcph900-cit-0025","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/epi.13416","article-title":"Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures","volume":"57","author":"Toledo","year":"2016","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0026|jcph900-cit-0026","first-page":"118","article-title":"Meta-analysis of non-psychotic behavioural treatment emergent adverse events in brivaracetam and levetiracetam development programmes","volume":"53","author":"D'Souza","year":"2012;","journal-title":"Epilepsia."},{"key":"10.1002\/jcph.900-BIB0027|jcph900-cit-0027","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/dmd.115.069161","article-title":"Effect of rifampin on the disposition of brivaracetam in human subjects: further insights into brivaracetam hydrolysis","volume":"44","author":"Stockis","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jcph.900-BIB0028|jcph900-cit-0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eplepsyres.2015.03.003","article-title":"Brivaracetam and carbamazepine interaction in healthy subjects and in vitro","volume":"113","author":"Stockis","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcph.900-BIB0029|jcph900-cit-0029","unstructured":"Moseley B Nicolas J Yeo K The effect of brivaracetam on the pharmacokinetics of phenytoin: in vivo, in vitro, and modeling studies. Poster presented at 70th Annual Meeting of the American Epilepsy Society; December 2016, Houston, TX"},{"key":"10.1002\/jcph.900-BIB0030|jcph900-cit-0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jcph.187","article-title":"Effect of brivaracetam (400 mg\/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women","volume":"53","author":"Stockis","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1002\/jcph.900-BIB0031|jcph900-cit-0031","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.12535","article-title":"Interaction between brivaracetam (100 mg\/day) and a combination oral contraceptive: a randomized, double blind, placebo-controlled study","volume":"55","author":"Stockis","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcph.900-BIB0032|jcph900-cit-0032","article-title":"Pharmacological interactions between brivaracetam and ethanol in healthy males [published online ahead of print September 20, 2016]","author":"Kruithof","journal-title":"J Psychopharmacol"},{"key":"10.1002\/jcph.900-BIB0033|jcph900-cit-0033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.seizure.2016.05.004","article-title":"Levetiracetam vs. brivaracetam for adults with refractor focal seizures: a meta-analysis and indirect comparison","volume":"39","author":"Lin","year":"2016","journal-title":"Seizure"},{"key":"10.1002\/jcph.900-BIB0034|jcph900-cit-0034","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1528-1167.2010.02915.x","article-title":"Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis","volume":"52","author":"Rheims","year":"2011","journal-title":"Epilepsia."},{"key":"10.1002\/jcph.900-BIB0035|jcph900-cit-0035","unstructured":"Cardinal Health www.cardinal.com 2016"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.900","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcph.900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T14:13:59Z","timestamp":1719152039000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.900"}},"subtitle":["Journal of Clinical Pharmacology"],"short-title":[],"issued":{"date-parts":[[2017,4,10]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.900","archive":["Portico"],"relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,10]]}}}